We have reviewed the literature and have identified more than 100 diseases or conditions
that are associated with raised concentrations of plasma total homocysteine. The …

Background: During the past decade, several clinical trials investigating the potential
benefits of homocysteine-lowering therapy for the secondary prevention of vascular events …

Background: Plasma homocysteine has been reported to be useful in the evaluation of
patients with suspected vitamin B12 or folate deficiency. In November 1998, Canada began …

Within-person and methodological variability of a given analyte are important elements in
determining whether an individual has altered concentrations of that analyte. We report the …

Elevated concentrations of homocysteine (Hcy) are associated with a range of disorders.
Linearity, imprecision, interference, method comparison, and accuracy were evaluated on …

An increase in homocysteine, a sulphur amino acid, is nowdays considered as a risk factor
for cardiovascular diseases, and is independent of other risk factors. Reference range for …

The biologically important amino acid homocysteine links sulfur, methionine, and one-
carbon metabolism. This review describes its initial discovery, the identification of the clinical …

Objectives: Hyperhomocysteinemia is associated with premature cerebral, peripheral and
coronary vascular disease. Evaluation of the significance of changes in plasma total …

Blood homocysteine is a major biomarker for cardiovascular as well as other disorders.
Several published studies reported inconsistent homocysteine levels with variable ranges …

Many studies have shown that increased plasma concentrations of total homocysteine (tHcy)
are associated with cardiovascular disease (1). Like most biological variables, plasma tHcy …